Coulie Bernard, President and CEO of Pliant Therapeutics, Inc. ($PLRX), made one open market sale of common shares in the last year, totaling $114,400. His most recent PLRX insider sale occurred on January 20, 2026. This activity ranks 9,370th among 11,678 insiders in our database, well below the average sale amount of $8.6 million over about 6.4 transactions. Coulie Bernard recorded no open market purchases in the past year.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 61,449,385 | 9999.99% | 0.53% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | D | Stock Option (Right to Buy) | 327262 | $0.00 | 0.0000 | 61,449,385 | 100.00% | 0.53% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 327262 | $0.00 | 327,262.0000 | 61,449,385 | 9999.99% | 0.53% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | D | Stock Option (Right to Buy) | 250000 | $0.00 | 0.0000 | 61,449,385 | 100.00% | 0.41% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 61,449,385 | 9999.99% | 0.41% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | D | Stock Option (Right to Buy) | 440000 | $0.00 | 0.0000 | 61,449,385 | 100.00% | 0.72% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 61,449,385 | 9999.99% | 0.72% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | D | Stock Option (Right to Buy) | 206300 | $0.00 | 0.0000 | 61,449,385 | 100.00% | 0.34% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 206300 | $0.00 | 206,300.0000 | 61,449,385 | 9999.99% | 0.34% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | D | Stock Option (Right to Buy) | 256300 | $0.00 | 0.0000 | 61,449,385 | 100.00% | 0.42% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 256300 | $0.00 | 256,300.0000 | 61,449,385 | 9999.99% | 0.42% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | D | Stock Option (Right to Buy) | 325000 | $0.00 | 0.0000 | 61,449,385 | 100.00% | 0.53% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | D | Stock Option (Right to Buy) | 146841 | $0.00 | 0.0000 | 61,449,385 | 100.00% | 0.24% |
| April 17, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 146841 | $0.00 | 146,841.0000 | 61,449,385 | 9999.99% | 0.24% |
| Jan. 22, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 1230000 | $0.00 | 1,230,000.0000 | 61,449,385 | 9999.99% | 2.00% |
| Jan. 20, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | S | Common Stock | 89375 | $1.28 | 914,918.0000 | 61,449,385 | 8.90% | 0.15% |
| June 17, 2025 | Septerna, Inc. | $SEPN | Coulie Bernard | Not found | A | Stock Option (Right to Buy) | 16623 | $0.00 | 16,623.0000 | 9,891,126 | 9999.99% | 0.17% |
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Common Stock | 162500 | $0.00 | 1,002,334.0000 | 0 | 19.35% | 0.00% |
| Jan. 17, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | S | Common Stock | 52419 | $11.20 | 839,834.0000 | 0 | 5.87% | 0.00% |
| July 10, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | S | Common Stock | 38710 | $11.56 | 892,253.0000 | 0 | 4.16% | 0.00% |
| July 9, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Common Stock | 75625 | $0.00 | 930,963.0000 | 0 | 8.84% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 256300 | $0.00 | 256,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | A | Common Stock | 128150 | $0.00 | 853,849.0000 | 0 | 17.66% | 0.00% |
| Jan. 17, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Coulie Bernard | President and CEO | S | Common Stock | 25721 | $17.23 | 725,699.0000 | 0 | 3.42% | 0.00% |